Glimisave MV 3.3 Tablet
Manufacturer
Eris Lifesciences Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.3mg) + Glimepiride (3mg)
Key Information
Short Description
Glimisave MV 3.3 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Dosage Form
Tablet SR
Introduction
Glimisave MV 3.3 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimisave MV 3.3 Tablet SR is to be taken empty stomach.
How it works
Glimisave MV 3.3 Tablet SR is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Volicure Trio 3mg/500mg/0.3mg Tablet SR
Apriglim-MV 303 Tablet
Vorgun GM 3mg/500mg/0.3mg Tablet SR
Voglow 0.3 GM3 Tablet SR
Synoglim MV 3.3 Tablet SR
Glimzab MV3 Tablet SR
Apriglave-MV3 Tablet SR
Glimisil MV 3mg/500mg/0.3mg Tablet SR
Voglow 0.3 GM3 Tablet SR
GPR-MV 3 Tablet SR
Frequently asked questions
What is Glimisave MV 3.3 Tablet SR?
Glimisave MV 3.3 Tablet SR is a combination medication containing glimepiride, metformin, and voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in conjunction with a healthy diet and regular exercise. This medication helps regulate blood sugar levels by increasing insulin release from the pancreas, reducing glucose production in the liver, and slowing down carbohydrate absorption in the gut.
What are the possible side effects of Glimisave MV 3.3 Tablet SR?
Common side effects of Glimisave MV 3.3 Tablet SR may include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare provider for guidance.
Are there any specific conditions in which Glimisave MV 3.3 Tablet SR should not be taken?
Glimisave MV 3.3 Tablet SR is contraindicated in patients with known allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis. Consult your doctor or healthcare provider before taking this medication if you have any of these conditions.
Is it safe to take alcohol while I am also taking Glimisave MV 3.3 Tablet SR?
No, it is not recommended to consume alcohol while taking Glimisave MV 3.3 Tablet SR. This combination may increase the risk of hypoglycemia and lactic acidosis. Avoid drinking alcohol while taking this medication, and consult your doctor or healthcare provider if you have any concerns.
Can the use of Glimisave MV 3.3 Tablet SR cause hypoglycemia?
Yes, Glimisave MV 3.3 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regularly monitor your blood sugar levels, and always keep glucose tablets, honey, or fruit juice with you. If you experience hypoglycemia, consult your doctor or healthcare provider for guidance.
What are the instructions for the storage and disposal of Glimisave MV 3.3 Tablet SR?
Store Glimisave MV 3.3 Tablet SR in its original packaging, tightly closed, according to the instructions provided on the pack or label. Dispose of any unused medication, and ensure it is not consumed by pets, children, or other individuals.
